ROS-driven hemispherical hydrogel micromotor and preparation method and application thereof

By using ROS to drive a hemispherical hydrogel micromotor in the treatment of inflammatory enteritis, using metal Pt in the ROS environment to catalyze O2 to promote the movement of microcarriers, and combined with the adhesion of dopamine, hydrogels in the prior art are solved. The poor targeting and insufficient pushing power of microcarriers have significantly improved the therapeutic effect.

CN119015445APending Publication Date: 2024-11-26NANJING DRUM TOWER HOSPITAL
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411254561.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-09
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing hydrogel microcarriers have poor targeting and insufficient driving force when treating inflammatory enteritis diseases, resulting in limited treatment effects, and few micromotor systems use excessive ROS accumulated in the intestinal area as fuel to drive themselves. Exercise to improve drug delivery efficiency.

Method used

Using the preparation method of ROS-driven hemispherical hydrogel micromotor, hemispherical hydrogel microspheres were prepared on a single-channel capillary microfluidic chip by functionalized dextran mixed solution, and the surface was sprayed with metal platinum and dopamine modification. , the metal Pt in the ROS environment catalyzes the generation of O2 to promote the movement of microcarriers, and combines the adhesion of dopamine to improve drug delivery efficiency.

Benefits of technology

It realizes autonomous exercise and drug delivery in the ROS environment, enhances the retention time and release ability of drugs in the intestine, significantly improves the oxidative stress environment in the intestine, reduces the inflammatory response, and relieves the symptoms of intestinal inflammation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015445A_ABST
    Figure CN119015445A_ABST
Patent Text Reader

Abstract

The invention discloses an ROS-driven hemispherical hydrogel micromotor and a preparation method and application thereof. A graphene oxide (GO) mixed functional glucan solution is quickly gelatinized in a histidine solution by using a microfluidic electronic injection technology to prepare hemispherical hydrogel microspheres; and then respectively coating platinum and dopamine on the surface and the bottom layer of the semispherical microsphere to obtain the semispherical hydrogel micromotor. The hydrogel micromotor can quickly react with ROS in the environment to generate oxygen so as to drive the hydrogel micromotor to move, and the hydrogel micromotor has good ROS removing capacity. Meanwhile, the dopamine coated on the bottom layer enables the hydrogel micromotor to achieve a strong adhesion effect on biological tissues. Based on a porous structure of the hemispherical hydrogel micromotor, therapeutic drug molecules are loaded in the hemispherical hydrogel micromotor, and the hemispherical hydrogel micromotor can be applied to the fields of targeted drug delivery, inflammatory bowel disease treatment and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomaterials, and specifically relates to a ROS-driven hemispherical hydrogel micromotor and a preparation method thereof, and the microspheres can be applied to the fields of targeted drug delivery, inflammatory bowel disease treatment, etc. Background Art

[0002] Inflammatory bowel disease (IBD) is an immune-mediated chronic intestinal inflammatory disease characterized by chronic recurrence, which can easily lead to intestinal flora imbalance, intestinal mucosal barrier damage, impaired immune function, and even colon cancer. In recent years, with the increasingly deteriorating living environment and unhealthy human living habits, the incidence of IBD has continued to rise. Studies have shown that reactive oxygen species (ROS) produced by gastrointestinal mucosa and infiltrating immune cells can cause severe inflammatory reactions and aggravate the progression of IBD. At present, the main clinical treatment of IBD is to regulate the intestinal mucosal immune response through oral anti-inflammatory drugs and probiotics. However, the therapeutic effect of oral drugs is unsatisfactory and is prone to systemic toxic side effects. The emergence of microcarrier delivery platform provides a possible solution to the above problems. It can enhance the therapeutic effect by loading therapeutic drugs into microspheres and releasing them in the intestinal system. Compared with the oral delivery system, the use of microcarriers can significantly increase the retention time of drugs in the body, thereby achieving long-term release of drugs. Although great progress has been made in the research of hydrogel microcarriers, they still have problems such as poor targeting and insufficient driving force, which leads to limited therapeutic effects. Therefore, it is urgent to develop a new type of hydrogel microcarrier with special microstructure and biological function as an intestinal drug carrier for the treatment of IBD.

[0003] A micromotor is a device that can convert external energy into mechanical motion. Inspired by the movement of natural microorganisms, researchers have developed a variety of micromotor systems with different morphologies and motion behaviors. Among many micromotor systems, their morphologies are mainly symmetrical structures, and their motion behaviors are triggered by uneven oscillations. Due to the characteristics of small size, self-propelled and easy preparation, micromotors have been widely used in drug delivery, minimally invasive surgery, and biological target sorting. Although many advances have been made in the research of micromotors, the problem of low retention efficiency due to the limited number of adhesion sites remains the main obstacle to the application of micromotor systems in vivo. The motion mechanism of micromotors is another key issue that needs to be considered during their preparation. In order to meet the treatment needs of IBD, researchers have designed micromotor systems driven by different motion mechanisms, including chemical, ultrasonic, magnetic or electric. Due to the excessive accumulation of reactive oxygen species in the inflammatory intestinal site, it has become a potential target for the treatment of IBD diseases. However, there are currently few micromotor systems that use the excessive ROS accumulated in the intestinal site as fuel to drive their own motion, and there are also few reports on micromotor systems that increase adhesion and improve drug delivery efficiency by designing a certain morphology. Summary of the invention

[0004] Purpose of the invention: The technical problem to be solved by the present invention is to provide a ROS-driven hemispherical hydrogel micromotor with a simple preparation method, uniform structure and good repeatability in view of the shortcomings of the prior art.

[0005] In order to achieve the above object, the technical solution adopted by the present invention is as follows: A method for preparing a ROS-driven hemispherical hydrogel micromotor comprises the following steps: (1) Preparation of functionalized dextran mixed solution: The benzaldehyde-modified dextran polymer, the cyanoacetate-modified dextran polymer, and the graphene oxide dispersion are uniformly mixed and dispersed to obtain a functionalized dextran mixed solution; (2) Preparation steps of hemispherical hydrogel microspheres: Assemble a single-channel capillary microfluidic chip, connect it to a syringe pump and a high-voltage power supply, and then inject the functionalized dextran mixed solution in step (1) into the histidine solution through the microfluidic chip to prepare hemispherical hydrogel microspheres; (3) Preparation of ROS-driven hemispherical hydrogel micromotors: The hemispherical hydrogel microspheres obtained in step (2) are spread on a plane, and metal platinum is evenly sprayed on the surface thereof by a high vacuum ion sputtering apparatus. Subsequently, the lower surface of the obtained hydrogel microspheres is immersed in a dopamine solution, and finally dried.

[0006] Furthermore, in step (1), the benzaldehyde-modified dextran polymer has a structure as shown in Formula I: Formula I; Wherein, x is the degree of polymerization, 10≤x≤500.

[0007] Furthermore, in step (1), the cyanoacetate-modified dextran polymer has a structure as shown in Formula II: Formula II; Wherein, y is the degree of polymerization, 10≤y≤500.

[0008] Furthermore, in the functionalized dextran mixed solution, the mass volume concentration of the benzaldehyde-modified dextran polymer is 5% to 30%, the mass volume concentration of the cyanoacetate-modified dextran polymer is 5% to 30%, and the concentration of graphene oxide is 4 mg / mL to 10 mg / mL. The solvent used is water, saline or PBS buffer solution.

[0009] Furthermore, in step (2), the mass concentration of the histidine solution is 5% to 20%, and the temperature is controlled at 4 to 37°C.

[0010] Furthermore, in step (2), the functionalized dextran mixed solution is pumped in at a flow rate of 3 mL / h to 8 mL / h, the voltage of the high-voltage power supply is 3 kv to 10 kv, and the distance between the nozzle of the capillary microfluidic chip and the histidine solution is 3 cm to 10 cm. By changing parameters such as the voltage, the distance between the chip device and the histidine solution, and the flow rate of the GO mixed solution, hydrogel microspheres with different radius sizes can be prepared.

[0011] Furthermore, in step (2), the radius of the obtained hemispherical hydrogel microspheres is 100 mm to 1000 mm.

[0012] Furthermore, in step (3), the time for spraying metal platinum is 10 s to 60 s, the time for immersing in the dopamine solution is 1 h to 12 h, and the mass volume concentration of the dopamine solution is 5% to 30%.

[0013] Furthermore, the ROS-driven hemispherical hydrogel micromotor prepared by the above preparation method is also within the protection scope of the present invention.

[0014] Furthermore, the present invention also claims the use of the above ROS-driven hemispherical hydrogel micromotor for targeted drug delivery. For example, in the treatment of inflammatory bowel disease, bioactive drug molecules such as dexamethasone or protein drugs are embedded in the pore structure of the microsphere to achieve targeted movement, drug delivery and tissue adhesion triggered by the ROS microenvironment. Beneficial Effects

[0015] (1) The present invention constructs a hemispherical hydrogel micromotor through microfluidic electrospraying technology, and its upper surface and chassis are modified with metal Pt and dopamine respectively. Once exposed to the ROS environment, the metal Pt on its upper surface will catalyze H2O2 to continuously produce O2, and the bubbles generated can further drive the microcarrier itself to move, and its movement behavior is positively correlated with the concentration of ROS. Since the bottom of the microcarrier is modified with dopamine, it has a good adhesion ability to tissues. Furthermore, the porous structure of the microcarrier gives it excellent drug loading and release capabilities. Based on these advantages, the constructed micromotor can achieve autonomous movement in a ROS environment, and its chassis can tightly adhere to the intestinal wall to enhance its drug release ability, and this process can also alleviate oxidative stress response and prolong the retention time of the micromotor in the body. Therefore, when it is used to treat IBD, the hemispherical hydrogel micromotor loaded with dexamethasone can significantly improve the oxidative stress environment in the intestine, reduce inflammatory response, and further alleviate the symptoms of enteritis. Therefore, the hemispherical micromotor drug carrier has broad clinical application prospects.

[0016] (2) The structure of the hemispherical hydrogel microspheres prepared in the present invention has obvious morphological anisotropy, and the upper surface and the bottom plane can be coated with different functional materials to achieve diversified functions and different modes of movement. The preparation method is simple, the formability is good, the operation is convenient, and the price is low. The prepared ROS-responsive hemispherical hydrogel microsphere micromotor can be used for drug delivery in the colon of animals and can be used for the treatment of inflammatory bowel diseases and other diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments, and the above and / or other advantages of the present invention will become more clear.

[0018] Figure 1 The NMR spectrum of the benzaldehyde-modified dextran polymer synthesized in the present invention.

[0019] Figure 2 The NMR spectrum of the cyanoacetate-modified dextran polymer synthesized in the present invention.

[0020] Figure 3 This is a light microscopic image of the hemispherical hydrogel microspheres prepared in Example 1 of the present invention.

[0021] Figure 4 This is a scanning electron microscope image of the hemispherical hydrogel micromotor prepared in Example 5 of the present invention.

[0022] Figure 5 The results of the movement of the hemispherical hydrogel micromotor prepared in Example 11 of the present invention in a hydrogen peroxide solution.

[0023] Figure 6 The adhesion of the hemispherical hydrogel micromotor prepared in Example 16 of the present invention to the mouse colon tissue under water flow impact.

[0024] Figure 7 These are the toxicity test results of the hemispherical hydrogel micromotor prepared in Example 17 of the present invention on mouse immortalized bone marrow-derived macrophages.

[0025] Figure 8 This is a fluorescent image of the hemispherical hydrogel micromotor prepared in Example 18 of the present invention being used to alleviate the level of reactive oxygen species in cells. DETAILED DESCRIPTION

[0026] The present invention can be better understood with reference to the following examples.

[0027] In the following examples, the preparation method of the benzaldehyde-modified dextran polymer is as follows: 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 4-dimethylaminopyridine are used as catalysts, which are added to a mixed solution of 4-formylbenzoic acid and dextran in dimethyl sulfoxide, and the benzaldehyde-modified dextran polymer shown in the formula is prepared through a dehydration reaction between the carboxyl and hydroxyl groups.

[0028] Formula I; Wherein, x is the degree of polymerization, and its specific value is 80. The NMR spectrum characterization results of the synthesized polymer are as follows Figure 1 shown.

[0029] The preparation method of the cyanoacetate-modified dextran polymer is as follows: 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 4-dimethylaminopyridine are used as catalysts, which are added to a mixed solution of cyanoacetic acid and dextran in dimethyl sulfoxide, and a cyanoacetate-modified dextran polymer as shown in formula II is prepared through a dehydration reaction between carboxyl and hydroxyl groups.

[0030] Formula II; Wherein, y is the degree of polymerization, and its specific value is 210. The NMR spectrum characterization results of the synthesized polymer are as follows Figure 2 shown. Example 1

[0031] The benzaldehyde-modified dextran polymer, the cyanoacetate-modified dextran polymer, and the graphene oxide dispersion are mixed and dispersed uniformly to obtain a functionalized dextran mixed solution; wherein, in the functionalized dextran mixed solution, the mass volume concentration of the benzaldehyde-modified dextran polymer is 10%, the mass volume concentration of the cyanoacetate-modified dextran polymer is 10%, the concentration of the graphene oxide is 5 mg / mL, and deionized water is used as the solvent.

[0032] After being mixed evenly, the mixed solution was injected into a single-channel microfluidic chip device, and the flow rate of the injection pump was adjusted to 5 mL / h and the voltage of the high-voltage power supply was adjusted to 4 kV. The dextran mixed solution was sprayed into a histidine solution (mass concentration of 10%, temperature controlled at 25 °C). The benzaldehyde and cyanoacetate groups on the dextran molecular chain reacted rapidly in the histidine solution, causing the mixed solution to gel, thereby obtaining hemispherical hydrogel microspheres. After the microspheres reacted in the histidine solution for 10 minutes, they were taken out and dried to obtain hemispherical hydrogel microspheres. The morphology of the hemispherical hydrogel microspheres obtained above was analyzed. Figure 3 This is a light microscopic image of the hemispherical hydrogel microspheres prepared in Example 1 of the present invention. Example 2

[0033] The configuration of the functionalized dextran mixed solution is the same as that in Example 1. After being mixed evenly, the mixed solution is injected into a single-channel microfluidic chip device, and the flow rate of the injection pump is adjusted to 5 mL / h and the voltage of the high-voltage power supply is adjusted to 6 kV. The dextran mixed solution is sprayed into the histidine solution, and the benzaldehyde and cyanoacetate groups on the dextran molecular chain react rapidly in the histidine solution to cause the mixed solution to gel, thereby obtaining hemispherical hydrogel microspheres. After the microspheres react in the histidine solution for 10 minutes, they are taken out and dried to obtain hemispherical hydrogel microspheres. Example 3

[0034] The configuration of the functionalized dextran mixed solution is the same as in Example 1. After being mixed evenly, the mixed solution is injected into a single-channel microfluidic chip device, and the flow rate of the injection pump is adjusted to 5 mL / h and the voltage of the high-voltage power supply is adjusted to 8 kV. The dextran mixed solution is sprayed into the histidine solution, and the benzaldehyde and cyanoacetate groups on the dextran molecular chain react rapidly in the histidine solution to cause the mixed solution to gel, thereby obtaining hemispherical hydrogel microspheres. After the microspheres react in the histidine solution for 10 minutes, they are taken out and dried to obtain hemispherical hydrogel microspheres. Example 4

[0035] The configuration of the functionalized dextran mixed solution is the same as in Example 1. After being mixed evenly, the mixed solution is injected into a single-channel microfluidic chip device, and the flow rate of the injection pump is adjusted to 5 mL / h and the voltage of the high-voltage power supply is adjusted to 10 kV. The dextran mixed solution is sprayed into the histidine solution, and the benzaldehyde and cyanoacetate groups on the dextran molecular chain react rapidly in the histidine solution to cause the mixed solution to gel, thereby obtaining hemispherical hydrogel microspheres. After the microspheres react in the histidine solution for 10 minutes, they are taken out and dried to obtain hemispherical hydrogel microspheres. Example 5

[0036] The hemispherical hydrogel microspheres prepared in Example 1 were spread on a surface dish, and then placed in a high vacuum ion sputtering apparatus and uniformly sprayed with metal platinum for 10 s to obtain a hydrogel hemisphere with platinum coated on the upper surface. The lower plane of the obtained microspheres was then immersed in a 10% (w / v) dopamine solution, and after 1 h, the hemispherical hydrogel micromotor was obtained after being taken out and dried at room temperature. The morphology of the hemispherical hydrogel micromotor obtained above was analyzed. Figure 4 This is a scanning electron microscope image of the hemispherical hydrogel micromotor prepared in Example 5 of the present invention. Example 6

[0037] The hemispherical hydrogel microspheres prepared in Example 1 were spread on a surface dish, and then placed in a high vacuum ion sputtering apparatus and uniformly sprayed with metal platinum for 20 s to obtain a hydrogel hemisphere with platinum coated on the upper surface. The lower plane of the obtained microspheres was then immersed in a 10% (w / v) dopamine solution, and after 1 hour, the hemispherical hydrogel micromotor was obtained by taking it out and drying it at room temperature. Example 7

[0038] The hemispherical hydrogel microspheres prepared in Example 1 were spread on a surface dish, and then placed in a high vacuum ion sputtering apparatus and uniformly sprayed with metal platinum for 30 seconds to obtain a hydrogel hemisphere with platinum coated on the upper surface. The lower plane of the obtained microspheres was then immersed in a 10% (w / v) dopamine solution, and taken out and dried at room temperature after 1 hour to obtain a hemispherical hydrogel micromotor. Example 8

[0039] The hemispherical hydrogel microspheres prepared in Example 1 were spread on a surface dish, and then placed in a high vacuum ion sputtering apparatus and uniformly sprayed with metal platinum for 10 s to obtain a hydrogel hemisphere with platinum coated on the upper surface. The lower plane of the obtained microspheres was then immersed in a 10% (w / v) dopamine solution, and after 2 h, the hemispherical hydrogel micromotor was obtained by taking it out and drying it at room temperature. Example 9

[0040] The hemispherical hydrogel microspheres prepared in Example 1 were spread on a surface dish, and then placed in a high vacuum ion sputtering apparatus and uniformly sprayed with metal platinum for 10 s to obtain a hydrogel hemisphere with platinum coated on the upper surface. The lower plane of the obtained microspheres was then immersed in a 10% (w / v) dopamine solution, and after 4 hours, the hemispherical hydrogel micromotor was obtained by taking it out and drying it at room temperature. Example 10

[0041] The hemispherical hydrogel microspheres prepared in Example 1 were spread on a surface dish, and then placed in a high vacuum ion sputtering apparatus and uniformly sprayed with metal platinum for 10 s to obtain a hydrogel hemisphere with platinum coated on the upper surface. The lower plane of the obtained microspheres was then immersed in a 10% (w / v) dopamine solution, and after 6 hours, the hemispherical hydrogel micromotor was obtained by taking it out and drying it at room temperature. Embodiment 11

[0042] The hemispherical hydrogel micromotor obtained in Example 9 was transferred to a 1% hydrogen peroxide solution and the movement of the micromotor was observed. Figure 5 In a 1% hydrogen peroxide solution, oxygen bubbles are generated on the upper surface of the micromotor to propel it to achieve directional movement. Example 12

[0043] The hemispherical hydrogel micromotor obtained in Example 9 was transferred to a 3% hydrogen peroxide solution to observe the movement of the micromotor therein. The results showed that in the 3% hydrogen peroxide solution, oxygen bubbles were generated on the upper surface of the micromotor to drive it to achieve directional movement. Example 13

[0044] The hemispherical hydrogel micromotor obtained in Example 9 was transferred to a 6% hydrogen peroxide solution to observe the movement of the micromotor therein. The results showed that in the 6% hydrogen peroxide solution, oxygen bubbles were generated on the upper surface of the micromotor to drive it to achieve directional movement. Embodiment 14

[0045] The hemispherical hydrogel micromotor obtained in Example 9 was transferred to a 9% hydrogen peroxide solution to observe the movement of the micromotor therein. The results showed that in the 9% hydrogen peroxide solution, oxygen bubbles were generated on the upper surface of the micromotor to drive it to achieve directional movement. Embodiment 15

[0046] The hemispherical hydrogel micromotor (20 mg) obtained in Example 9 was transferred to a 3% hydrogen peroxide solution, and then 50 mL of hydrogen peroxide solution was absorbed at different times, and the change curve of the hydrogen peroxide content over time was detected by the titanium sulfate test method. When the hydrogen peroxide was consumed, the same concentration of 3% hydrogen peroxide solution was added again to observe the ability of the hemispherical hydrogel micromotor to repeatedly catalyze the degradation of hydrogen peroxide. Example 16

[0047] The lower surface of the hemispherical hydrogel micromotor coated with dopamine obtained in Example 9 was adhered to the surface of the mouse colon tissue skin, and then placed under a flowing water flow to observe the adhesion of the hydrogel microspheres to the mouse colon tissue. Figure 6 The hemispherical hydrogel micromotors have good adhesion to the mouse colon tissue. By counting the initial microsphere adhesion amount on the colon tissue and the number of microsphere adhesion after water flushing, the adhesion rate of the hemispherical hydrogel microspheres on the mouse colon tissue was specifically counted. Embodiment 17

[0048] Mouse immortalized bone marrow-derived macrophages (iBMDM) were seeded into sterile 96-well plates (10 3 / well, 150 μL DMEM / well), and then placed it in a sterile incubator for culture. After 12 hours, the old culture medium was discarded, and 150 μL DMEM culture medium containing hydrogel micromotor extract was added to each well. After culturing for 24, 48 and 72 hours, CCK-8 reagent was added to each well, and the absorbance value of each well at 450 nm was measured by a microplate reader. Then, live / dead staining reagent was added to each well to observe the survival of iBMDM cells. The cell compatibility test results of hemispherical hydrogel micromotors can be found in Figure 7 ,The experimental results showed that the hemispherical hydrogel micromotors had no cytotoxicity to the mouse immortalized bone marrow-derived macrophage cell line. Embodiment 18

[0049] iBMDM were seeded in sterile 24-well plates (10 5 / well, 1 mL DMEM / well), and then placed it in a sterile incubator for culture. After overnight culture, 10 mM hydrogen peroxide solution was added to each well and cultured for another 12 h. Then 10 mg of hydrogel micromotors were added to the culture medium and incubated for 12 h. The old culture medium was discarded, 1 mL of fresh DMEM culture medium solution was added, and DCFH-DA reactive oxygen species detection probe reagent was added to test the intracellular hydrogen peroxide level. Results are shown in Figure 8 ,The experimental results show that the hemispherical hydrogel micromotors can effectively alleviate the ROS level in cells. Embodiment 19

[0050] iBMDM were seeded in sterile 24-well plates (10 5 / well, 1 mL DMEM / well), and then placed it in a sterile incubator. After overnight culture, 1 mg / mL lipopolysaccharide (LPS) was added to each well, and the culture was continued for 12 h, and 10 mg hydrogel micromotors were added to each well. After the cells were placed in the incubator and continued to be cultured for 24 h, the cell culture medium supernatant was collected. The group with 1 mg / mL LPS was used as the control group. The levels of cellular inflammatory factors such as TNF-α, IL-6 and IL-1b were determined by enzyme-linked immunosorbent assay (ELISA) kits, and the absorbance values ​​of the samples at 450 nm were determined by microplate reader. The results showed that after stimulating iBMDM cells with LPS, the expression level of proinflammatory cytokines was significantly increased, while the addition of hydrogel micromotors significantly reduced the expression level of proinflammatory cytokines. Therefore, the hemispherical hydrogel micromotors can effectively alleviate the inflammatory response of iBMDM cells.

[0051] The present invention provides a ROS-driven hemispherical hydrogel micromotor and its preparation method and application ideas and methods. There are many methods and ways to implement the technical solution. The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention. All components not specified in this embodiment can be implemented by existing technologies.

Claims

1. A method for preparing a ROS-driven hemispherical hydrogel micromotor, characterized in that: The steps include: (1) Preparation of functionalized dextran mixed solution: The benzaldehyde-modified dextran polymer, the cyanoacetate-modified dextran polymer, and the graphene oxide dispersion are uniformly mixed and dispersed to obtain a functionalized dextran mixed solution; (2) Preparation steps of hemispherical hydrogel microspheres: Assemble a single-channel capillary microfluidic chip, connect it to a syringe pump and a high-voltage power supply, and then inject the functionalized dextran mixed solution in step (1) into the histidine solution through the microfluidic chip to prepare hemispherical hydrogel microspheres; (3) Preparation of ROS-driven hemispherical hydrogel micromotors: The hemispherical hydrogel microspheres obtained in step (2) are spread on a plane, and metal platinum is evenly sprayed on the surface thereof by a high vacuum ion sputtering apparatus. Subsequently, the lower surface of the obtained hydrogel microspheres is immersed in a dopamine solution, and finally dried.

2. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In step (1), the benzaldehyde-modified dextran polymer has a structure as shown in Formula I: Formula I; Wherein, x is the degree of polymerization, 10≤x≤500.

3. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In step (1), the cyanoacetate-modified dextran polymer has a structure as shown in Formula II: Formula II; Wherein, y is the degree of polymerization, 10≤y≤500.

4. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In the functionalized dextran mixed solution, the mass volume concentration of the benzaldehyde-modified dextran polymer is 5% to 30%, the mass volume concentration of the cyanoacetate-modified dextran polymer is 5% to 30%, and the concentration of graphene oxide is 4 mg / mL to 10 mg / mL.

5. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In step (2), the mass concentration of the histidine solution is 5% to 20%, and the temperature is controlled at 4 to 37°C.

6. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In step (2), the functionalized dextran mixed solution is pumped in at a flow rate of 3 mL / h to 8 mL / h, the voltage of the high-voltage power supply is 3 kV to 10 kV, and the distance between the nozzle of the capillary microfluidic chip and the histidine solution is 3 cm to 10 cm.

7. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In step (2), the radius of the obtained hemispherical hydrogel microspheres is 100 mm to 1000 mm.

8. The method for preparing the ROS-driven hemispherical hydrogel micromotor according to claim 1, characterized in that: In step (3), the time for spraying metal platinum is 10 s to 60 s, the time for immersing in the dopamine solution is 1 h to 12 h, and the mass volume concentration of the dopamine solution is 5% to 30%.

9. The ROS-driven hemispherical hydrogel micromotor prepared by the preparation method according to any one of claims 1 to 8.

10. Use of the ROS-driven hemispherical hydrogel micromotor according to claim 9 in targeted drug delivery.

Citation Information

Cited By

  • MnFe2O4 / biomass-based photo-Fenton motor as well as preparation method and application thereof

    CN120861171A